Calyxt (NASDAQ:CLXT) reported quarterly losses of $(0.14) per share which missed the analyst consensus estimate of $(0.13) by 7.69 percent. This is a 33.33 percent increase over losses of $(0.21) per share from the same period last year.
Sonoma Pharmaceuticals Q1 EPS $(0.29) Up From $(0.52) YoY, Sales $3.98M Up From $3.68M YoY
Sonoma Pharmaceuticals (NASDAQ:SNOA) reported quarterly losses of $(0.29) per share. This is a 44.23 percent increase over losses of $(0.52) per share from the same period last year. The company reported $3.98 million
